Table des matières 2007-2008 - IRCM

Are pleiotropic effects of HMG-coA reductase inhibitors(statins) clinically significant? Is there an impact of thepleiotropic effects of lipid lowering drugs in the treatment ofthe metabolic syndrome? Satellite Symposium de laFondation Coeur et Artères of the 5th MetabolicSyndrome, Type II Diabetes and AtherosclerosisCongress (MSDA), Marrakech, MarocJacques de CHAMPLAINLa santé cardiovasculaire des canadiens: Défis etperspectives. Symposium « La prise en charge desfacteurs de risque cardiovasculaire : pourquoi etcomment? » 16 e Congrès annuel de la SociétéQuébécoise d’Hypertension Artérielle, Montréal,QuébecRôle du stress oxidatif dans l’hypertension artérielle,Symposium de la Société des sciences vasculaires duQuébec (SSVQ), Montréal, QuébecChristian F. DESCHEPPERMatters of the heart: Sex, genetics, and early lifeexperience, 23 rd Annual Scientific Meeting of theAmerican Society of Hypertension, New Orleans,LouisianaJavier M. DI NOIAThe role of AID and UNG in antibody gene diversification,21 ième Conférence annuelle de la Société Canadiennepour l’Immunologie, Mont-Tremblant, QuébecJacques DROUINMolecular pathogenesis of hormone resistance andtumorigenesis in Cushing disease, InternationalConference on the Adrenal Cortex (Adrenal 2008), SanFrancisco, CalifornieThe HPA axis and convergence of LIF/Stat3 andglucocorticoid pathways, 7th Congress of theInternational Society for NeuroimmunoModulation, Riode Janeiro, BrésilControl of cell cycle and differentiation during pituitaryorganogenesis, 4 th Canadian Developmental BiologyConference, Banff, CalgaryControl of cell cycle exit and differentiation during pituitarydevelopment, The 1st Kumamoto University GlobalCenter-of-Excellence (COE) Symposium on Cell fateregulation, Kumamoto, JaponPituitary precursors and differentiation, Workshop onDevelopmental program, rhythms and networks in thehypothalamus, pituitary and pancreas, Lauret, FranceMolecular mechanism of glucocorticoid resistance inCushing disease, 10 th International Pituitary Congress,Chicago, IllinoisRobert DUFOURTraitement des dyslipidémies : parfaire le savoir actuelpour mieux relever les défis, Symposium satellite duSymposium francophone de médecine, Montréal,QuébecLes études cliniques majeures en 2007-2008 : CORONA etTNT-HDL. 9 e réunion annuelle de la Sociétéquébécoise de lipidologie, de nutrition et demétabolisme, Laval, QuébecYvan GUINDONSynthesis of natural products, free radical-basedmethodologies, 91st Canadian Chemistry Conferenceand Exhibition, Edmonton, AlbertaFree Radicals in Synthesis, 10 th InternationalSymposium on Organic Free Radicals and 3 rd PacificSymposium on Radical Chemistry, Heron Island,AustraliaMarko HORBThe role of Ptf1a in converting liver, stomach, andduodenum to pancreas, Second Annual Retreat of theMontreal Diabetes Research Center, Montreal, QuebecPaul JOLICŒURGeneration of a novel inducible model of AIDS. ColdSpring Harbor Retroviruses Meeting, 2008, NY, USA.Maxime LAMARRE-CLICHEDysautonomie et personne âgée, Congrès scientifiqueannuel de l’Association des médecins gériatres duQuébec, Montréal, QuébecMarie KMITARole of Hox genes in early and late limb development,Experimental Biology Meeting, San Diego, Californie55